stocks Pharmacyclics Inc

J&J beats forecasts, helped by new medicines
10:45 AM ET Tue, 15 April 2014
Johnson & Johnson turned in a solid first quarter Tuesday, topping analysts' profit and revenue estimates and increasing its 2014 earnings forecast by 5 cents a share.
Midday movers: Herbalife, Eli Lilly, Cray & More
5:14 PM ET Tue, 7 Jan 2014
Some of Tuesday's midday movers:
Early movers: AAL, TWC, DIS, AAPL & more
4:15 PM ET Mon, 9 Dec 2013
Some of the names on the move ahead of the open.
Lightning Round: Apple, Arena Pharma & More
6:48 PM ET Mon, 11 Nov 2013
It’s time for the Lightning Round. Cramer makes the call on viewer favorites.
Lightning round: Wolverine World Wide and more
7:26 PM ET Mon, 4 Nov 2013
"Mad Money" host Jim Cramer made calls on stocks viewers asked about.
Cramer: Biggest blockbuster drug in ages?
7:09 PM ET Fri, 27 Sept 2013
Cramer wants you to know about the company behind this potential breakthrough cancer drug.
Cramer: Easy Money Over, Ring the Register
7:04 PM ET Mon, 1 July 2013
The trick to successful investing is knowing when to take profits and walk away. In this case, Cramer says it’s time.
10 Best-Performing Biopharma Stocks of 2012 and Their 2013 Outlook
9:41 AM ET Sat, 1 Dec 2012
TheStreet.com details the 10 best-performing biopharmaceutical stocks of 2012 and their outlook for 2013.
No Magic in Anti-Obesity Pills and Profits
1:44 PM ET Tue, 17 July 2012
Jim Cramer’s researcher, Nicole Urken, reiterates the importance of assessing risk when speculating.
Your All-Star in Cramer's #StockDerby
7:07 PM ET Tue, 10 July 2012
Find out which second-quarter top performer got the most votes.
Vote for Your All-Star in Cramer's #StockDerby
9:18 PM ET Mon, 9 July 2012
Tell Cramer which second-quarter top performer is your All-Star!
Major Wave of Biotech Mergers Expected
2:54 PM ET Thu, 26 Jan 2012
Amgen and Celgene, looking to boost oncology offerings, announced separate deals for small biotech companies Thursday, the latest in what analysts expect to be a major wave of biotech mergers.
Turning Up the Heat (Again) on the FDA
3:18 PM ET Thu, 5 Aug 2010
For the second time in two weeks, an op-ed item appears in The Wall Street Journal today calling out the FDA for its record on timely approval of cancer drugs.
FDA And Migraine Drug Trexima: Caution Is The Prescription
1:56 PM ET Thu, 5 Aug 2010
This morning we learned that the FDA has issued another "approvable" letter to Pozen and GlaxoSmithKline for their migraine drug Trexima over safety concerns. POZN shares are down big. The company has scheduled a conference call for 11 a.m. ET. This is the third regulatory stumbling block for this drug and puts it on a timeline now where it could end up competing...

« First

var mps=mps||{}; mps._queue=mps._queue||{}; mps._queue.gptloaded=mps._queue.gptloaded||[]; mps._queue.gptloaded.push(function() { (mps && mps.insertAd && mps.insertAd('#dart_wrapper_badgec', 'badgec')); }); stocks Pharmacyclics Inc

stocks Pharmacyclics Inc